Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography

Circ J. 2009 Jun;73(6):1033-7. doi: 10.1253/circj.cj-08-0746. Epub 2009 Apr 14.

Abstract

Background: Sirolimus-eluting stents (SES) have incomplete neointimal coverage at 6-month follow up as determined with optical coherence tomography (OCT). The long-term detailed changes of neointima in SES remains to be clarified.

Methods and results: Serial changes in neointimal coverage of SES from 6 months to 12 months using OCT were examined. Of 21 SES in 13 patients, OCT was used to visualize 2,321 stent struts at 6 months and 2,285 stent struts at 12 months. The frequency of struts without neointimal coverage decreased from 6 months to 12 months (from 10.4 to 5.7%). The frequency of malapposed struts decreased from 6 months to 12 months (from 1.7 to 0.2%). The average thickness of the neointima increased (from 112 +/-123 to 120 +/-130 microm). The frequency of struts located at the side branch orifice without neointima decreased (from 4 out of 17 (24%) to 0 out of 17 (0%)). Complete coverage with neointima was observed in 14% (3 of 21 SES) at 6 months, and 24% (5 of 21 SES) at 12 months.

Conclusions: Additional neointimal coverage was observed between 6 and 12 months, with a small increase in the neointimal thickness. The incidence of complete coverage, however, was still low at 12 months. These findings suggest delayed neointimalization on SES.

MeSH terms

  • Aged
  • Coronary Thrombosis / epidemiology
  • Coronary Thrombosis / physiopathology
  • Coronary Vessels / pathology
  • Coronary Vessels / physiopathology*
  • Drug-Eluting Stents*
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / diagnosis*
  • Neovascularization, Pathologic / physiopathology*
  • Risk Factors
  • Sirolimus*
  • Time Factors
  • Tomography, Optical Coherence*
  • Tunica Intima / pathology
  • Tunica Intima / physiopathology*

Substances

  • Sirolimus